Radiotherapy for benign disorders: current use in clinical practice
- PMID: 34002817
- DOI: 10.26355/eurrev_202105_25824
Radiotherapy for benign disorders: current use in clinical practice
Abstract
Objective: The aim of this paper is to provide an update about the current clinical indications of RT in this poorly explored field outside the traditional oncological setting.
Materials and methods: We performed a literature search on the main databases, including PubMed, Scopus and Cochrane from their inception until 31st December 2020. An additional manual check of scientific meeting proceedings and books was conducted in order to identify all the potentially useful sources. Only essays published in English have been considered for the purposes of this analysis. The searched items included: "Radiotherapy or Radiation Therapy" and "Benign disorder or Benign disease".
Results: We provided a list of current clinical indications for benign disorders based on the latest international surveys available, including major sites: eye, bone, head and neck, skin, brain, heart and peripheral vascular system.
Conclusions: Radiotherapy for benign diseases is still a feasible therapeutic strategy, which may allow to treat several invalidating conditions, especially after medical therapies have failed thus avoiding potentially invalidating major surgical procedures. A careful evaluation in selecting the indication is essential and all the choices should be thoroughly discussed with the patients.
Similar articles
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.Oncologist. 1997;2(1):59-61. Oncologist. 1997. PMID: 10388030
-
Psychometric properties of self-report concussion scales and checklists.J Athl Train. 2012 Mar-Apr;47(2):221-3. doi: 10.4085/1062-6050-47.2.221. J Athl Train. 2012. PMID: 22488289 Free PMC article.
-
Health Technology Assessment of Carbon-ion Beam Radiotherapy: A Systematic Review of Clinical Effectiveness and Safety for 54 Oncological Indications in 12 Tumour Regions.Anticancer Res. 2019 Apr;39(4):1635-1650. doi: 10.21873/anticanres.13269. Anticancer Res. 2019. PMID: 30952702
-
Radiomics: A primer for the radiation oncologist.Cancer Radiother. 2020 Aug;24(5):403-410. doi: 10.1016/j.canrad.2020.01.011. Epub 2020 Apr 4. Cancer Radiother. 2020. PMID: 32265157 Review.
Cited by
-
Cutaneous Vascular Neoplasms of Uncertain Biological Behavior.Biology (Basel). 2021 Nov 9;10(11):1160. doi: 10.3390/biology10111160. Biology (Basel). 2021. PMID: 34827153 Free PMC article. Review.
-
What Would Become of Nuclear Risk if Governments Changed Their Regulations to Recognize the Evidence of Radiation's Beneficial Health Effects for Exposures That Are Below the Thresholds for Detrimental Effects?Dose Response. 2021 Nov 26;19(4):15593258211059317. doi: 10.1177/15593258211059317. eCollection 2021 Oct-Dec. Dose Response. 2021. PMID: 34880717 Free PMC article.
-
Implementing a low-dose radiation therapy program for musculoskeletal pain disorders: tips, tricks, and essentials for clinical researchers.Clin Transl Oncol. 2025 Apr 27. doi: 10.1007/s12094-025-03936-8. Online ahead of print. Clin Transl Oncol. 2025. PMID: 40287913
-
A Rare Cardiac Cavernous Hemangioma Treated with Radiotherapy.Case Rep Vasc Med. 2022 Sep 5;2022:5698475. doi: 10.1155/2022/5698475. eCollection 2022. Case Rep Vasc Med. 2022. PMID: 36105488 Free PMC article.
-
The 5Rs dilemma of radiotherapy for non-malignant diseases: 5Rs to darken OR 5Rs to shine.Rep Pract Oncol Radiother. 2023 Apr 6;28(1):74-78. doi: 10.5603/RPOR.a2023.0001. eCollection 2023. Rep Pract Oncol Radiother. 2023. PMID: 37122917 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical